Key result
Measuring APC resistance without dilution in factor V-deficient plasma identified 24 APC-resistant subjects, detecting potentially important thrombotic risk factors other than factor V Leiden.
Why the study?
Does measuring APC resistance without dilution in factor V-deficient plasma detect thrombotic risk factors other than Factor V Leiden?
Case-Control (n=65)
Blinded
Does measuring APC resistance without dilution in factor V-deficient plasma detect thrombotic risk factors other than Factor V Leiden?
Measuring APC resistance without dilution in factor V-deficient plasma can identify potentially important thrombotic risk factors beyond Factor V Leiden.
Answers are grounded in this paper and cite their sources.
May identify non-FVL thrombotic risks; hypothesis-generating and requires validation before clinical adoption.
Activated protein C (APC) resistance is a common risk factor for venous thromboembolism (VTE) attributed to various mechanisms, including factor V Leiden (FVL) polymorphism. FVL is considered responsible for up to 95% of APC resistance; however, other factor V polymorphisms and elevated factor VIII levels also have been implicated. We assessed whether additional mechanisms contribute to APC resistance in a blinded case-control study of 65 subjects by measuring APC resistance using 3 methods: 2 activated partial thromboplastin time-based methods with and without dilution in factor V-deficient plasma and 1 Russell viper venom-based assay (RVV). Without factor V-deficient plasma, 24 subjects were APC resistant; with factor V-deficient plasma, the assay identified fewer APC-resistant subjects, as did RVV. All assays detected the 7 heterozygous FVL subjects. Thirteen subjects had factor VIII levels above 150% (1.50). After excluding subjects with FVL or elevated factor VIII levels, 4 subjects still had APC resistance. VTE risk trended higher for subjects with APC resistance in the absence of FVL. Measurement of APC resistance without dilution in factor V-deficient plasma is needed to assess for potentially important thrombotic risk factors other than FVL.
No takes yet. Share an insight, caveat, or question.
Qamar et al. (2003) conducted a case-control in Venous thromboembolism (VTE) and Activated protein C (APC) resistance (n=65). Activated protein C (APC) resistance assay without dilution in factor V-deficient plasma vs. Assays with dilution in factor V-deficient plasma or Russell viper venom-based assay was evaluated on Detection of APC resistance. Measuring APC resistance without dilution in factor V-deficient plasma identified 24 APC-resistant subjects, detecting potentially important thrombotic risk factors other than factor V Leiden.
Synapse has enriched 10 related papers. Consider them for comparative context: